Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000713696 | SCV000344689 | uncertain significance | not provided | 2018-06-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713696 | SCV000589856 | uncertain significance | not provided | 2018-11-13 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the SYNE1 gene. The V3226I variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The V3226I variant is observed in 34/10238 (0.3%) alleles from individuals of African background, in the ExAC dataset (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The V3226I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Valine are tolerated across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Athena Diagnostics Inc | RCV000713696 | SCV000844323 | likely benign | not provided | 2018-12-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001079193 | SCV001005075 | likely benign | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000713696 | SCV004010622 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | SYNE1: BS1 |
Prevention |
RCV003930184 | SCV004743897 | likely benign | SYNE1-related condition | 2019-04-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |